Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0002007919-24-000058
Filing Date
2024-11-14
Accepted
2024-11-14 16:02:55
Documents
67
Period of Report
2024-09-30

Document Format Files

Seq Description Document Type Size
1 10-Q inhibrx-20240930.htm   iXBRL 10-Q 992550
2 EX-31.1 exhibit311q32024.htm EX-31.1 10312
3 EX-31.2 exhibit312q32024.htm EX-31.2 10322
4 EX-32.1 exhibit321q32024.htm EX-32.1 5100
5 EX-32.2 exhibit322q32024.htm EX-32.2 5097
11 inhibrx-20240930_g1.jpg GRAPHIC 166858
12 inhibrx-20240930_g2.jpg GRAPHIC 162808
  Complete submission text file 0002007919-24-000058.txt   6569963

Data Files

Seq Description Document Type Size
6 XBRL TAXONOMY EXTENSION SCHEMA DOCUMENT inhibrx-20240930.xsd EX-101.SCH 44347
7 XBRL TAXONOMY EXTENSION CALCULATION LINKBASE DOCUMENT inhibrx-20240930_cal.xml EX-101.CAL 51457
8 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE DOCUMENT inhibrx-20240930_def.xml EX-101.DEF 232570
9 XBRL TAXONOMY EXTENSION LABEL LINKBASE DOCUMENT inhibrx-20240930_lab.xml EX-101.LAB 562470
10 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE DOCUMENT inhibrx-20240930_pre.xml EX-101.PRE 399416
70 EXTRACTED XBRL INSTANCE DOCUMENT inhibrx-20240930_htm.xml XML 690276
Mailing Address 11025 N. TORREY PINES ROAD, SUITE 140 LA JOLLA CA 92037
Business Address 11025 N. TORREY PINES ROAD, SUITE 140 LA JOLLA CA 92037 (858) 795-4220
Inhibrx Biosciences, Inc. (Filer) CIK: 0002007919 (see all company filings)

EIN.: 990613523 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 001-42031 | Film No.: 241461638
SIC: 2836 Biological Products, (No Diagnostic Substances)
(CF Office: 03 Life Sciences)